Skip to content

13F-HR/A filed by MONTANOVA CAPITAL, LLC

MONTANOVA CAPITAL, LLC filed this 13F-HR/A for the quarter ended 2021-09-30, filed 2021-11-16, with 106 holding rows worth $5,935,377,000.

Accession
0001172661-21-002406
Filed
2021-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, amendment of type restatement, 106 entries on the cover page, a total value of $5,935,377,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,935,377,000 with VALUE read as thousands by filing date, 13F file number 028-15929. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Adobe Inc00724F101COM634,613$365,359,000thousands by filing date
Amazon.com, Inc023135106COM99,137$325,669,000thousands by filing date
UnitedHealth Group Inc91324P102COM715,113$279,423,000thousands by filing date
MasterCard, Inc57636Q104COM674,400$234,475,000thousands by filing date
RH74967X103COM334,951$223,382,000thousands by filing date
OTIS WORLDWIDE CORP COM68902V107Stock2,699,539$222,118,000thousands by filing date
TAPESTRY INC COM876030107Stock5,378,032$199,095,000thousands by filing date
OPENDOOR TECHNOLOGIES INC683712103COM9,446,879$193,944,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM325,810$186,145,000thousands by filing date
GFL ENVIRONMENTAL INC SUB VTG SHS36168Q104Stock4,715,117$175,167,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock703,187$168,441,000thousands by filing date
TWILIO INC CL A90138F102Stock516,520$164,796,000thousands by filing date
Union Pacific Corporation907818108COM819,697$160,669,000thousands by filing date
QUANTA SVCS INC74762E102COM1,388,834$158,077,000thousands by filing date
LAUDER ESTEE COS INC CL A518439104Stock513,414$153,988,000thousands by filing date
CENCORA INC COM03073E105Stock1,234,845$147,502,000thousands by filing date
CARVANA CO CL A146869102Stock479,143$144,481,000thousands by filing date
ANAPLAN INC03272L108COM2,165,238$131,841,000thousands by filing date
ROSS STORES INC COM778296103Stock1,117,935$121,687,000thousands by filing date
COPART INC COM217204106Stock872,764$121,070,000thousands by filing date
KBR INC COM48242W106Stock2,983,377$117,545,000thousands by filing date
Medtronic PlcG5960L103COM911,226$114,222,000thousands by filing date
CANO HEALTH INC13781Y103COM8,419,011$106,753,000thousands by filing date
PELOTON INTERACTIVE INC70614W100CL A COM1,166,800$101,570,000thousands by filing date
ALIGHT INC01626W101COM CL A8,350,000$95,858,000thousands by filing date
NATERA INC COM632307104Stock747,220$83,270,000thousands by filing date
TE CONNECTIVITY LTDH84989104SHS603,877$82,864,000thousands by filing date
Analog Devices,Inc.032654105COM477,645$79,996,000thousands by filing date
HOWMET AEROSPACE INC COM443201108Stock2,551,230$79,598,000thousands by filing date
BLOCK INC CL A852234103Stock302,930$72,655,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM1,311,748$60,537,000thousands by filing date
MasterCard, Inc57636Q104COM172,600$60,010,000thousands by filing datecall
ROYALTY PHARMA PLCG7709Q104SHS CLASS A1,527,900$55,218,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK1,941,969$54,783,000thousands by filing date
WARBY PARKER INC93403J106CL A COM1,000,000$53,050,000thousands by filing date
NXP SEMICONDUCTORS N V COMN6596X109Stock256,438$50,229,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK1,251,946$46,673,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock2,460,202$46,080,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM2,233,695$42,194,000thousands by filing date
ELASTIC N V ORD SHSN14506104Stock271,000$40,376,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM191,308$33,844,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW507,088$30,197,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM862,126$29,295,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock998,732$27,505,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM1,543,284$26,930,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q200COM NEW2,197,426$25,007,000thousands by filing date
MEREO BIOPHARMA GROUP PLC589492107CMN9,142,067$22,124,000thousands by filing date
FREYR BATTERYL4135L100SHS2,093,710$20,665,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock1,704,589$17,762,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock1,158,961$17,709,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM2,157,727$17,154,000thousands by filing date
POINT BIOPHARMA GLOBAL INC730541109COM2,225,000$17,110,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM1,325,500$16,768,000thousands by filing date
HERON THERAPEUTICS INC427746102COM1,490,440$15,933,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock5,974,193$14,278,000thousands by filing date
DICE THERAPEUTICS INC23345J104COM410,000$13,428,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM1,047,468$13,366,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM1,409,956$12,182,000thousands by filing date
ROCKET LAB USA INC773122106COM750,000$12,098,000thousands by filing date
SIO GENE THERAPIES INC829399104COM5,489,000$11,911,000thousands by filing date
CHIMERIX INC COM16934W106Stock1,907,620$11,808,000thousands by filing date
TERNS PHARMACEUTICALS INC COM880881107Stock1,125,736$11,730,000thousands by filing date
CAZOO GROUP LTDG2007L105COM1,509,700$11,730,000thousands by filing date
INOZYME PHARMA INC45790W108COM986,400$11,432,000thousands by filing date
PROMETHEUS BIOSCIENCES INC74349U108COM480,480$11,392,000thousands by filing date
FINSERV ACQUISITION CORP II31809Y103COM1,092,600$10,631,000thousands by filing date
BIOATLA INC09077B104COM354,190$10,427,000thousands by filing date
GEMINI THERAPEUTICS INC36870G105CMN2,137,823$8,637,000thousands by filing date
Inflarx NvN44821101COM3,285,000$8,508,000thousands by filing date
EVOLV TECHNOLOGIES HLDNGS IN30049H102COM CL A1,367,870$8,207,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM489,333$7,864,000thousands by filing date
MOLECULAR PARTNERS AG60853G106ADS400,000$7,844,000thousands by filing date
NERDY INC64081V109CL A COM700,000$6,993,000thousands by filing date
ARCHER AVIATION INC03945R102COM CL A750,000$6,660,000thousands by filing date
AC IMMUNE SAH00263105SHS963,500$6,465,000thousands by filing date
FRESHWORKS INC CLASS A COM358054104Stock150,000$6,404,000thousands by filing date
IMMUNEERING CORP45254E107CLASS A COM200,000$5,310,000thousands by filing date
NEXIMMUNE INC65344D109COM344,223$5,212,000thousands by filing date
RESEARCH ALLIANCE CORP II760873109CMN500,000$4,925,000thousands by filing date
Milestone Pharmaceuticals Inc59935V107COM851,291$4,861,000thousands by filing date
MONTES ARCHIMEDES ACQUISITIO612657106COM CL A500,000$4,675,000thousands by filing date
OTONOMY INC68906L105COM2,387,700$4,584,000thousands by filing date
NUVALENT INC COM670703107Stock200,000$4,510,000thousands by filing date
PARDES BIOSCIENCES INC COM30318F100Stock400,000$3,980,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM149,100$3,118,000thousands by filing date
HEALTHCOR CATALIO ACQU CORPG44125105CL A SHS300,000$2,970,000thousands by filing date
OMEGA ALPHA SPACG6749V107CL A300,000$2,921,000thousands by filing date
EUROPEAN BIOTECH ACQUTN CORPG3167F102CLASS A ORD SHS300,000$2,901,000thousands by filing date
CANO HEALTH INC13781Y111WARR674,566$2,786,000thousands by filing date
Benitec Biopharma, Inc.08205P100common769,000$2,745,000thousands by filing date
VOLTA INC92873V102COM CL A300,000$2,595,000thousands by filing date
Alight Inc01626W119Warrant / Rights774,375$2,362,000thousands by filing date
DECIBEL THERAPEUTICS INC24343R106COM263,600$2,032,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN200,000$1,992,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T108CMN200,000$1,958,000thousands by filing date
NAUTILUS BIOTECHNOLOGY INC63909J108COM314,835$1,933,000thousands by filing date
FOGHORN THERAPEUTICS INC344174107COMMON STOCK84,000$1,170,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W106CMN99,999$978,000thousands by filing date
FRAZIER LIFESCIENCES ACQU COG3710A105CMN87,498$859,000thousands by filing date
ADAGENE INC005329107CMN42,722$614,000thousands by filing date
FINSERV ACQUISITION CORP II31809Y111*W EXP 02/17/202273,149$243,000thousands by filing date
SYNLOGIC INC87166L100COM60,000$183,000thousands by filing date
EUROPEAN BIOTECH ACQUTN CORPG3167F128*W EXP 03/06/202100,000$62,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T124WTS66,666$46,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W122*W EXP 10/23/20233,333$24,000thousands by filing date
FRAZIER LIFESCIENCES ACQU COG3710A113WTS29,166$20,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-21-002311 superseded2021-11-15acceptance time not in the bulk data set
13F-HR/A 0001172661-21-002342 superseded2021-11-15acceptance time not in the bulk data set
13F-HR/A 0001172661-21-002406this filing2021-11-16acceptance time not in the bulk data set